Drug Information

Drug General Information
Drug ID
D0UV8T
Former ID
DNC010090
Drug Name
4-(1H-1,2,3-triazol-5-yl)pyridine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530623]
Formula
C7H6N4
Canonical SMILES
C1=CN=CC=C1C2=NNN=C2
InChI
1S/C7H6N4/c1-3-8-4-2-6(1)7-5-9-11-10-7/h1-5H,(H,9,10,11)
InChIKey
KEFBRERBEDJOQZ-UHFFFAOYSA-N
PubChem Compound ID
9942176
Target and Pathway
Target(s) Indoleamine 2,3-dioxygenase Target Info Inhibitor [530623]
BioCyc Pathway Superpathway of tryptophan utilization
Tryptophan degradation
L-kynurenine degradation
Tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde
NAD de novo biosynthesis
KEGG Pathway Tryptophan metabolism
Metabolic pathways
African trypanosomiasis
NetPath Pathway TSLP Signaling Pathway
IL5 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
PathWhiz Pathway Tryptophan Metabolism
Reactome Tryptophan catabolism
WikiPathways Tryptophan metabolism
Metabolism of amino acids and derivatives
References
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.